Japanese pharmaceutical companies have shown significant growth with 9% increased outpatient prescriptions

Japanese pharmaceutical companies have made significant increases in the outpatient prescription market on the first quarter.

According to the Medipana News’s analysis result of outpatient prescription expenses of the first quarter of 2015, turned by 6 major Japanese pharmaceutical companies based on the UBIST data, 5 pharmaceutical companies have showed growth.

The total outpatient prescript...